By inhibiting the expression of NLRP3, the occurrence of pyroptosis can be suppressed, thus alleviating the inflammatory response of NAFLD (Ruan et al., 2021). This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.